Private Trust Company’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3
Closed -$305 2635
2025
Q4
$305 Sell
3
-146
-98% -$11.7K ﹤0.01% 2474
2025
Q3
$8.15K Sell
149
-70
-32% -$3.5K ﹤0.01% 1985
2025
Q2
$11.6K Buy
+219
New +$11.1K ﹤0.01% 1761
2024
Q4
Sell
-26
Closed -$1.77K 2352
2024
Q3
$1.77K Hold
26
﹤0.01% 2162
2024
Q2
$1.1K Hold
26
﹤0.01% 2195
2024
Q1
$1.8K Sell
26
-250
-91% -$15.8K ﹤0.01% 2124
2023
Q4
$20.4K Sell
276
-202
-42% -$13.2K ﹤0.01% 1392
2023
Q3
$32.6K Sell
478
-2
-0.4% -$170 ﹤0.01% 1166
2023
Q2
$45.1K Buy
+480
New +$37.4K 0.01% 1068

Other funds holding EXAS

Private Trust Company's EXAS Position: Q1 2026 in Review

Private Trust Company sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3 shares — an estimated $305 sold.

Private Trust Company first reported a position in EXAS in Q2 2023 and held it in 9 quarters. The position peaked at $45.1K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Private Trust Company reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Private Trust Company sold 3 Exact Sciences shares in Q1 2026, an estimated $305.
  • Private Trust Company first reported a position in Exact Sciences in Q2 2023 and held it in 9 quarters.
  • Private Trust Company's Exact Sciences position peaked at $45.1K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.